Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TTE8T73)

• DTT Name: Wiskott-Aldrich syndrome protein (WAS) DTT Info
• Gene Name: WAS

Molecule-Related Drug & Molecule List

3 Clinical Trial Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
OTL-103	DM3BK2Y	Wiskott-Aldrich syndrome	3B62.0	Phase 3	[1]
Hematopoietic stem cell gene therapy	DMQWI7V	Wiskott-Aldrich syndrome	3B62.0	Phase 1/2	[2]
WASP gene therapy	DMN62MP	Wiskott-Aldrich syndrome	3B62.0	Phase 1/2	[3]

References

• [1] Clinical pipeline report, company report or official report of Orchard Therapeutics.
• [2] Development of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome. Curr Opin Mol Ther. 2006 Oct;8(5):390-5.
• [3] ClinicalTrials.gov (NCT01347242) Gene Therapy for Wiskott-Aldrich Syndrome (WAS). U.S. National Institutes of Health.